The data above suggests elderly CD8+ T cells have reduced effector function and increased suppressive function, therefore we assessed the cytolytic capacity of young vs. elderly tumor-specific CD8+ T cells in TDLNs and tumors after two doses of IL-2/CD40 using an in vivo CTL assay. The gene discussed is IL2; the disease is neoplasm.